Navigation Links
Blood Pressure Control in Middle Age Can Lower Lifetime Heart Risk
Date:12/19/2011

MONDAY, Dec. 19 (HealthDay News) -- Blood pressure changes in middle age can affect your lifetime risk for heart disease and stroke, a new study suggests.

U.S. researchers analyzed data from almost 62,000 people whose blood pressure readings were tracked for an average of 14 years.

People who kept or lowered their blood pressure to normal levels by age 55 had the lowest lifetime risk (22 percent to 41 percent) for heart disease. The risk for people who had high blood pressure at age 55, however, was 42 percent to 69 percent.

When all blood pressure levels were factored in, the overall lifetime heart disease risk for people over the age of 55 was about 53 percent for men and about 40 percent for women.

"This study adds to our existing knowledge that hypertension is the most important modifiable risk factor for cardiovascular disease, including coronary heart disease and stroke," said expert Dr. Robert Graham, an internist at Lenox Hill Hospital in New York City. "Unfortunately, many patients do not take this 'silent disease' seriously because they usually don't see or feel the effects of their hypertension until some catastrophic outcome has occurred," he added.

Among the other findings:

  • Women generally had higher increases in middle age than men, and women who have high blood pressure by early middle age (average age 41) have a higher lifetime risk for heart disease (49 percent) than those who have maintained normal blood pressure up to age 55.
  • At an average age of 55, 26 percent of men had normal blood pressure, as did 41 percent of women, while about 49 percent of men and 48 percent of women had prehypertension.
  • Nearly 70 percent of men who develop high blood pressure in middle age will experience a cardiovascular event such as a stroke or heart attack by age 85, the team found.

The study appears Dec. 19 in the journal Circulation.

"Taking blood pressure changes into account can provide more accurate estimates for lifetime risk of cardiovascular disease, and it can help us predict individualized risk, and thus, individualized prevention strategies," study author Norrina Allen, an assistant professor in the department of preventive medicine at the Northwestern University Feinberg School of Medicine, in Chicago, explained in a journal news release.

"Both avoiding hypertension during middle age or delaying the onset of the development of hypertension appear to have a significant impact on an individual's remaining lifetime risk for CVD," Allen noted.

Graham agreed. He said that hypertension in middle age "can affect one's lifetime risk for heart disease and stroke. Fortunately, with medications and lifestyle changes, patients who control their blood pressure during middle age had the lowest lifetime risk of cardiovascular disease, while those with an increase in blood pressure had the highest risk."

More information

The U.S. National Heart, Lung, and Blood Institute offers a guide to lowering high blood pressure.

-- Robert Preidt

SOURCE: Robert Graham, M.D., internist, Lenox Hill Hospital, New York City; Circulation, news release, Dec. 15, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Brief, Intense Exercise Lowers Blood Sugar, Small Study Finds
2. Less blood needed post-surgery, says NEJM study
3. Team designs a bandage that spurs, guides blood vessel growth
4. Blood test might predict how well a depressed patient responds to antidepressants
5. Low Iron Levels May Increase Blood Clot Risk
6. Key genetic error found in family of blood cancers
7. University of Maryland finds restricting post-surgery blood transfusion is safe for some hip patients
8. Study Finds Fewer Blood Transfusions Needed After Hip Surgeries
9. Cancer Outpatients at Greater Risk for Blood Clots
10. Bone marrow and blood stem cell transplant survival rates equal, when donor is unrelated to patient
11. Massive DNA search uncovers new mutations driving blood cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Pressure Control in Middle Age Can Lower Lifetime Heart Risk
(Date:5/26/2016)... ... May 26, 2016 , ... Georgia State University College ... academic programs. , Answering to the increasing demand for curricular specializations, the Certificate ... and environmental and land use law. ,  , “The demand for lawyers with ...
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For ... their lives in military battle for the country. The nonprofit Hope For Heroes ... more programs that empower independence for disabled military veterans, as well as police, firemen, ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... one that has a significant negative impact on long-term patient survival, reports a ... The results, published online this week in the Journal of Thoracic and Cardiovascular ...
(Date:5/26/2016)... ... 2016 , ... MadgeTech will be showcasing its line of data logging ... at the MadgeTech headquarters. With products sold in more than 100 countries around the ... NASA. , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech data ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James Maisel will ... Long Island Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public ... Retina Group of New York , is a Board Certified ophthalmologist who ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... WELLESLEY, Massachusetts , May 26, 2016 ... sequencing (NGS) has matured into an essential life science ... research and development applications. BCC Research reveals in its ... of a second growth phase, one powered by a ... applied fields.      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ...
(Date:5/25/2016)... May 25, 2016 According to ... Type (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic ... User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to ... Medical Animation Market for the forecast period of 2016 ... 301.3 Million by 2021 from USD 117.3 Million in ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, ... QGEN ; Frankfurt Prime Standard: QIA) today announced that the ... Therawis Diagnostics GmbH to develop and commercialize predictive assays in ... PITX2 as a marker to predict effectiveness of anthracycline treatment ... "We are pleased to partner with Therawis, which developed ...
Breaking Medicine Technology: